Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 3901–3950 of 75328
The Conley Amendment provides that Mr. Conley’s employment term will terminate automatically upon the consummation of the transactions contemplated by Purchase Agreement.
On June 4, 2025, Ian Taylor, Ph.D., President of Research and Development of Arvinas, Inc. (the “Company”), notified the Company of his decision to resign his employment with the Company and retire, effective June 6, 2025
On June 2, 2025, Thomas DeRosa was appointed as the President and as a director by the AppTech Payments Corp.
who resigned effective May 19, 2025, as previously announced on Form 8-K filed with the Securities and Exchange Commission on May 19, 2025.
The Board of Directors (the “Board”) of the Company appointed Josh Neman as the Company’s Chief Clinical Officer, effective June 5, 2025.
On June 4, 2025, the employment of D. Clay Bretches, Executive Vice President of Operations of APA Corporation, was terminated.
Also on June 6, 2025, the Company appointed Caleb Van Dolah as the Company’s principal accounting officer, effective as of June 15, 2025.
On June 6, 2025, it was determined that Kelly Rosser will no longer serve as Chief Accounting Officer of Net Power Inc. (the “Company”), effective as of June 15, 2025 (the “Effective Date”).
On May 30, 2025 , Lisa Y. Foo was promoted to Chief Operating Officer of Tenet Healthcare Corporation (the “Company”), a newly created position within the Company, effective immediately.
Mr. David M. Hession notified Dorman Products, Inc. (the “Company”) of his intention to retire as Senior Vice President and Chief Financial Officer (“CFO”) of the Company later this year.
As reported on the Original 8-K, as of the Effective Time (as defined in the Original 8-K), the Capital One board of directors (the 'Board') increased its size to 15 directors and appointed each of Thomas G. Maheras, Michael Shepherd and Jennifer L. Wong (each, a 'New Director' and, collectively, the 'New Directors') to join the Board.
As reported on the Original 8-K, as of the Effective Time (as defined in the Original 8-K), the Capital One board of directors (the 'Board') increased its size to 15 directors and appointed each of Thomas G. Maheras, Michael Shepherd and Jennifer L. Wong (each, a 'New Director' and, collectively, the 'New Directors') to join the Board.
As reported on the Original 8-K, as of the Effective Time (as defined in the Original 8-K), the Capital One board of directors (the 'Board') increased its size to 15 directors and appointed each of Thomas G. Maheras, Michael Shepherd and Jennifer L. Wong (each, a 'New Director' and, collectively, the 'New Directors') to join the Board.
Effective as of June 2, 2025, Don Hawk’s six-month term of employment serving as Executive Director, Product Innovation of TechTarget, Inc. (the “Company”) expired
On June 2, 2025, MarketAxess Holdings Inc. (the “Company”) appointed Nitin A. Mirwani as its Chief Accounting Officer, effective upon his start date with the Company, which is expected to be June 23, 2025.
Michael R. Cianciulli will cease serving as the Company’s interim principal accounting officer as of the Effective Date, but will continue to serve as the Company’s Head of External Reporting & Compensation Accounting.
On June 1, 2025, Tim Van Hauwermeiren resigned from the Board of Directors (the " Board ") of iTeos Therapeutics, Inc. (the " Company "), effective immediately.
On June 4, 2025, Tan Sze Thuan, a member of the Board of Directors (the “Board”) of Scorpius Holdings, Inc., a Delaware corporation (the “Company”), notified the Company of his decision to resign, effective immediately, from his position as a member of the Board.
On June 3, 2025, the Board of Directors of EGH Acquisition Corp. (the “Company”) appointed Michelle Kley, age 53, as Chief Legal Officer and Corporate Secretary, effective immediately.
On June 4, 2025, Jeffrey D. Harris, Treasurer and Chief Financial Officer of Glen Burnie Bancorp (the “ Company ”) since 2017, advised the Company’s Board of Directors that he intends to retire on June 30, 2025.
Tom Lynch and Peter Lee were appointed to the board of directors (the “Board”) of The Cannabist Company Holdings Inc.
Tom Lynch and Peter Lee were appointed to the board of directors (the “Board”) of The Cannabist Company Holdings Inc.
the board expanded the size of the Board from ten directors to twelve directors and appointed Aashima Gupta to serve as a Class III director
Upon and subject to the completion of the Merger, Joseph B. Reilly, Provident’s Director, President and Chief Executive Officer will join the respective Boards of Directors of the Company and Needham Bank.
On March 12, 2025, Omnicell, Inc. (“Omnicell” or the “Company”) filed a Current Report on Form 8-K disclosing that Nchacha Etta would step down from his role as Executive Vice President, Chief Financial Officer of the Company, effective September 15, 2025 or until a successor is named.
On May 30, 2025, Ms. Heather Isidoro notified the Board of Directors (the “Board”) of Barnwell Industries, Inc. (the “Company”) that she resigned as a director of the Company, effective May 30, 2025.
Simultaneously with the promotion of Mr. Tick, C. Bradford Richmond resigned as the Company’s Interim Chief Executive Officer. In order to facilitate the transition, Mr. Richmond will serve as Special Advisor to the Chief Executive Officer through August 22, 2025
Thomas A. Houdek, the Chief Financial Officer and a Senior Vice President of the Company, notified the Company that he would be leaving the Company effective June 20, 2025.
Lyle D. Tick, the Company’s current President and Chief Concept Officer, had been promoted to the role of Chief Executive Officer and President effective June 5, 2025
On June 2, 2025, Steven J. Heyer notified the Board of Directors (the “Board”) of biote Corp. (the “Company”) of his resignation as a member of the Board, effective immediately.
As previously disclosed, on April 21, 2025, the Board of Directors (the “Board”) of Sight Sciences, Inc. (the “Company”), upon the recommendation of its Nominating and Corporate Governance Committee, appointed Gerhard F. Burbach to the Board.
Following Ms. Miller’s departure, Elena Gomez, the Company’s President and Chief Financial Officer, will serve as the Company’s Interim Chief Accounting Officer and interim principal accounting officer.
On June 3, 2025, Toast, Inc. (the “Company”) and Gail Miller mutually agreed that her employment as the Company’s Chief Accounting Officer will end effective June 13, 2025.
On June 1, 2025, the Board of Directors (the “Board”) of Digimarc Corporation (the “Company”) approved the appointment of Carle Quinn as the Company’s Chief Operating Officer, effective immediately.
each of Conrad Yiu, Matthew Clunies-Ross and Luke Fay resigned as a Board observer
each of Lynne Thornton, Niraj Javeri and Stuart Hutton resigned as a director of the board of directors
each of Conrad Yiu, Matthew Clunies-Ross and Luke Fay resigned as a Board observer
Enrique Klix will assume the role of Chief Financial Officer of the Company
each of Lynne Thornton, Niraj Javeri and Stuart Hutton resigned as a director of the board of directors
Oliver Matlock resigned as the Chief Financial Officer of the Company
each of Lynne Thornton, Niraj Javeri and Stuart Hutton resigned as a director of the board of directors
each of Conrad Yiu, Matthew Clunies-Ross and Luke Fay resigned as a Board observer
On May 30, 2025, the Board of Directors of Apimeds Pharmaceuticals US, Inc. (the “Company”) appointed Erick J. Frim as Chief Financial Officer of the Company, replacing Mark Corrao.
On May 30, 2025, the Board of Directors of Apimeds Pharmaceuticals US, Inc. (the “Company”) appointed Erick J. Frim as Chief Financial Officer of the Company, replacing Mark Corrao.
Following the consummation of the Business Combination, Ibrahima Sory Tall was appointed as the sole director and President of the Company.
On June 1, 2025, Jonathan R. Furer resigned as a director of the board of directors (the “ Board ”) of Live Oak Acquisition Corp. V (the “ Company ”), and as a member of committees of the Board, effective immediately.
On June 2, 2025, the Board determined to place Mr. Mewawalla on administrative leave from his position as Chief Executive Officer and President of the Company, effective immediately
appointed Mr. Kaliste Saloom to serve as Interim Chief Executive Officer of the Company, effective as of June 3, 2025.
appointed Mr. Tianping Cai to serve on the Board of Directors of the Company.
Mr. Rosenbloom stepped down as the Chief Financial Officer of the Company on April 17, 2025, and continues to serve in a senior advisory role as Executive Vice President of Finance.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.